{"id":808955,"date":"2025-02-05T06:33:47","date_gmt":"2025-02-05T11:33:47","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/"},"modified":"2025-02-05T06:33:47","modified_gmt":"2025-02-05T11:33:47","slug":"bio-techne-declares-dividend-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/","title":{"rendered":"Bio-Techne Declares Dividend"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">MINNEAPOLIS<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Feb. 5, 2025<\/span><\/span> \/PRNewswire\/ &#8212;\u00a0Bio-Techne\u00a0Corporation\u00a0(NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of <span class=\"xn-money\">$0.08<\/span> per share for the quarter ended <span class=\"xn-chron\">December 31, 2024<\/span>. The quarterly dividend will be payable <span class=\"xn-chron\">February 28, 2025<\/span>, to all common shareholders of record on <span class=\"xn-chron\">February 17, 2025<\/span>. Future cash dividends will be considered by the Board of Directors on a quarterly basis.<\/p>\n<p>Bio-Techne\u00a0Corporation\u00a0(NASDAQ:\u00a0TECH)\u00a0is\u00a0a\u00a0global\u00a0life\u00a0sciences company\u00a0providing\u00a0innovative tools\u00a0and\u00a0bioactive reagents\u00a0for\u00a0the\u00a0research and\u00a0clinical\u00a0diagnostic\u00a0communities.\u00a0Bio-Techne\u00a0products assist\u00a0scientific\u00a0investigations\u00a0into\u00a0biological\u00a0processes and\u00a0the\u00a0nature\u00a0and progress\u00a0of\u00a0specific\u00a0diseases. They aid\u00a0in\u00a0drug\u00a0discovery\u00a0efforts and\u00a0provide\u00a0the\u00a0means\u00a0for\u00a0accurate\u00a0clinical tests\u00a0and\u00a0diagnoses.\u00a0With\u00a0thousands\u00a0of\u00a0products\u00a0in\u00a0its\u00a0portfolio,\u00a0Bio-Techne\u00a0generated\u00a0approximately\u00a0$1.2 billion\u00a0in\u00a0net\u00a0sales in\u00a0fiscal\u00a02024 and has approximately\u00a03,100 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio\u00ad techne.com.<\/p>\n<p>Forward Looking Statements:<br \/>Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. Forward looking statements in this press release include statements regarding potential future repurchase of Bio-Techne common stock. The following important factors, among others, have affected and, in the future, could affect the Company&#8217;s actual results and future share price: the effect of new branding and marketing initiatives, the integration of new businesses and leadership, the introduction and acceptance of new products, the funding and focus of the types of research by the Company&#8217;s customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, customer site closures or supply chain issues, the impact of currency exchange rate fluctuations, and the costs and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed strategic relationships.<\/p>\n<p>For additional information concerning such factors, see the section titled &#8220;Risk Factors&#8221; in the Company&#8217;s annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements we make in our press releases due to new information or future events. Investors are cautioned not to place undue emphasis on these statements.<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"0\" class=\"prnbcc\">\n<tr>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Contact:<\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen2\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">David\u00a0Clair, Vice President, Investor Relations &amp; Corporate Development<br \/><a href=\"mailto:David.Clair@bio-techne.com\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">David.Clair@bio-techne.com<\/a><br \/>612-656-4416<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2666\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg\" title=\"BT Logo (PRNewsfoto\/Bio-Techne Corporation)\" alt=\"BT Logo (PRNewsfoto\/Bio-Techne Corporation)\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>\u00a0<\/p>\n<p>\n        <span>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span>\n      <\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder0\"><\/div>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=CG11916&amp;sd=2025-02-05\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/bio-techne-declares-dividend-302368598.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/bio-techne-declares-dividend-302368598.html<\/a><\/p>\n<p>SOURCE  Bio-Techne Corporation<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CG11916&amp;Transmission_Id=202502050630PR_NEWS_USPR_____CG11916&amp;DateId=20250205\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire MINNEAPOLIS , Feb. 5, 2025 \/PRNewswire\/ &#8212;\u00a0Bio-Techne\u00a0Corporation\u00a0(NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2024. The quarterly dividend will be payable February 28, 2025, to all common shareholders of record on February 17, 2025. Future cash dividends will be considered by the Board of Directors on a quarterly basis. Bio-Techne\u00a0Corporation\u00a0(NASDAQ:\u00a0TECH)\u00a0is\u00a0a\u00a0global\u00a0life\u00a0sciences company\u00a0providing\u00a0innovative tools\u00a0and\u00a0bioactive reagents\u00a0for\u00a0the\u00a0research and\u00a0clinical\u00a0diagnostic\u00a0communities.\u00a0Bio-Techne\u00a0products assist\u00a0scientific\u00a0investigations\u00a0into\u00a0biological\u00a0processes and\u00a0the\u00a0nature\u00a0and progress\u00a0of\u00a0specific\u00a0diseases. They aid\u00a0in\u00a0drug\u00a0discovery\u00a0efforts and\u00a0provide\u00a0the\u00a0means\u00a0for\u00a0accurate\u00a0clinical tests\u00a0and\u00a0diagnoses.\u00a0With\u00a0thousands\u00a0of\u00a0products\u00a0in\u00a0its\u00a0portfolio,\u00a0Bio-Techne\u00a0generated\u00a0approximately\u00a0$1.2 billion\u00a0in\u00a0net\u00a0sales in\u00a0fiscal\u00a02024 and has approximately\u00a03,100 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio\u00ad techne.com. Forward Looking Statements:Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Bio-Techne Declares Dividend&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-808955","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bio-Techne Declares Dividend - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bio-Techne Declares Dividend - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire MINNEAPOLIS , Feb. 5, 2025 \/PRNewswire\/ &#8212;\u00a0Bio-Techne\u00a0Corporation\u00a0(NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2024. The quarterly dividend will be payable February 28, 2025, to all common shareholders of record on February 17, 2025. Future cash dividends will be considered by the Board of Directors on a quarterly basis. Bio-Techne\u00a0Corporation\u00a0(NASDAQ:\u00a0TECH)\u00a0is\u00a0a\u00a0global\u00a0life\u00a0sciences company\u00a0providing\u00a0innovative tools\u00a0and\u00a0bioactive reagents\u00a0for\u00a0the\u00a0research and\u00a0clinical\u00a0diagnostic\u00a0communities.\u00a0Bio-Techne\u00a0products assist\u00a0scientific\u00a0investigations\u00a0into\u00a0biological\u00a0processes and\u00a0the\u00a0nature\u00a0and progress\u00a0of\u00a0specific\u00a0diseases. They aid\u00a0in\u00a0drug\u00a0discovery\u00a0efforts and\u00a0provide\u00a0the\u00a0means\u00a0for\u00a0accurate\u00a0clinical tests\u00a0and\u00a0diagnoses.\u00a0With\u00a0thousands\u00a0of\u00a0products\u00a0in\u00a0its\u00a0portfolio,\u00a0Bio-Techne\u00a0generated\u00a0approximately\u00a0$1.2 billion\u00a0in\u00a0net\u00a0sales in\u00a0fiscal\u00a02024 and has approximately\u00a03,100 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio\u00ad techne.com. Forward Looking Statements:Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve &hellip; Continue reading &quot;Bio-Techne Declares Dividend&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-05T11:33:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Bio-Techne Declares Dividend\",\"datePublished\":\"2025-02-05T11:33:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/\"},\"wordCount\":426,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2470019\\\/Bio_Techne_Corporation__logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/\",\"name\":\"Bio-Techne Declares Dividend - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2470019\\\/Bio_Techne_Corporation__logo.jpg\",\"datePublished\":\"2025-02-05T11:33:47+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2470019\\\/Bio_Techne_Corporation__logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2470019\\\/Bio_Techne_Corporation__logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/bio-techne-declares-dividend-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bio-Techne Declares Dividend\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bio-Techne Declares Dividend - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/","og_locale":"en_US","og_type":"article","og_title":"Bio-Techne Declares Dividend - Market Newsdesk","og_description":"PR Newswire MINNEAPOLIS , Feb. 5, 2025 \/PRNewswire\/ &#8212;\u00a0Bio-Techne\u00a0Corporation\u00a0(NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended December 31, 2024. The quarterly dividend will be payable February 28, 2025, to all common shareholders of record on February 17, 2025. Future cash dividends will be considered by the Board of Directors on a quarterly basis. Bio-Techne\u00a0Corporation\u00a0(NASDAQ:\u00a0TECH)\u00a0is\u00a0a\u00a0global\u00a0life\u00a0sciences company\u00a0providing\u00a0innovative tools\u00a0and\u00a0bioactive reagents\u00a0for\u00a0the\u00a0research and\u00a0clinical\u00a0diagnostic\u00a0communities.\u00a0Bio-Techne\u00a0products assist\u00a0scientific\u00a0investigations\u00a0into\u00a0biological\u00a0processes and\u00a0the\u00a0nature\u00a0and progress\u00a0of\u00a0specific\u00a0diseases. They aid\u00a0in\u00a0drug\u00a0discovery\u00a0efforts and\u00a0provide\u00a0the\u00a0means\u00a0for\u00a0accurate\u00a0clinical tests\u00a0and\u00a0diagnoses.\u00a0With\u00a0thousands\u00a0of\u00a0products\u00a0in\u00a0its\u00a0portfolio,\u00a0Bio-Techne\u00a0generated\u00a0approximately\u00a0$1.2 billion\u00a0in\u00a0net\u00a0sales in\u00a0fiscal\u00a02024 and has approximately\u00a03,100 employees worldwide. For more information on Bio-Techne and its brands, please visit www.bio\u00ad techne.com. Forward Looking Statements:Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve &hellip; Continue reading \"Bio-Techne Declares Dividend\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-05T11:33:47+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Bio-Techne Declares Dividend","datePublished":"2025-02-05T11:33:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/"},"wordCount":426,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/","name":"Bio-Techne Declares Dividend - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg","datePublished":"2025-02-05T11:33:47+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2470019\/Bio_Techne_Corporation__logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/bio-techne-declares-dividend-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Bio-Techne Declares Dividend"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/808955","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=808955"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/808955\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=808955"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=808955"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=808955"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}